Ardent Health (NYSE:ARDT) Price Target Lowered to $12.00 at JPMorgan Chase & Co.

Ardent Health (NYSE:ARDT) had its target price reduced by stock analysts at JPMorgan Chase & Co. from $15.00 to $12.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 33.48% from the stock’s previous close.

Several other equities research analysts also recently issued reports on ARDT. Leerink Partners set a $16.00 price target on shares of Ardent Health in a research note on Friday, November 14th. Mizuho dropped their target price on Ardent Health from $20.00 to $13.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 18th. Royal Bank Of Canada reduced their price target on Ardent Health from $21.00 to $16.00 and set an “outperform” rating for the company in a report on Friday, November 14th. Weiss Ratings downgraded Ardent Health from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, November 17th. Finally, KeyCorp cut Ardent Health from an “overweight” rating to a “sector weight” rating in a research note on Monday, November 17th. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ardent Health currently has an average rating of “Hold” and a consensus target price of $15.00.

Ardent Health Trading Up 0.6%

NYSE:ARDT traded up $0.05 during trading hours on Monday, reaching $8.99. 107,242 shares of the company were exchanged, compared to its average volume of 424,596. The firm has a market cap of $1.29 billion, a price-to-earnings ratio of 6.20, a PEG ratio of 7.34 and a beta of 0.44. The stock has a 50 day simple moving average of $13.34 and a 200 day simple moving average of $13.19. Ardent Health has a 52-week low of $8.28 and a 52-week high of $17.34. The company has a debt-to-equity ratio of 0.67, a current ratio of 2.08 and a quick ratio of 1.95.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.10. Ardent Health had a return on equity of 19.02% and a net margin of 3.24%.The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.55 billion. Ardent Health has set its FY 2025 guidance at 0.850-1.030 EPS. As a group, analysts predict that Ardent Health will post 1.23 EPS for the current year.

Hedge Funds Weigh In On Ardent Health

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Ardent Health by 368.9% during the 1st quarter. Vanguard Group Inc. now owns 1,330,635 shares of the company’s stock worth $18,296,000 after purchasing an additional 1,046,845 shares during the period. Goldman Sachs Group Inc. increased its position in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock worth $10,558,000 after buying an additional 724,841 shares during the period. Ameriprise Financial Inc. lifted its stake in Ardent Health by 75.6% in the second quarter. Ameriprise Financial Inc. now owns 1,634,822 shares of the company’s stock valued at $22,332,000 after buying an additional 703,739 shares during the last quarter. SageView Advisory Group LLC grew its position in shares of Ardent Health by 367.2% during the second quarter. SageView Advisory Group LLC now owns 790,663 shares of the company’s stock worth $10,800,000 after acquiring an additional 621,430 shares during the last quarter. Finally, Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of Ardent Health in the 3rd quarter worth about $6,377,000.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.